Skip to content 
Search

Latest Stories

Simple blood test enhances accuracy in bipolar disorder diagnosis: Study

The blood test could be an effective complement to existing psychiatric diagnosis and can help researchers understand the biological origins of mental health conditions

Simple blood test enhances accuracy in bipolar disorder diagnosis: Study

Scientists at the University of Cambridge have created a simple blood test that, when paired with an online psychiatric assessment, enhances the accuracy of diagnosing bipolar disorder.

When used independently, the blood test could identify 30% of patients with bipolar disorder. However, it was found that its efficacy significantly increased when combined with a digital mental health assessment.


Incorporating biomarker testing could help physicians differentiate between major depressive disorder and bipolar disorder, which have overlapping symptoms but require different pharmacological treatments.

Although the blood test is still a proof of concept, the study published in the journal JAMA Psychiatry found that it could be an effective complement to existing psychiatric diagnosis and can help researchers understand the biological origins of mental health conditions.

Bipolar disorder affects approximately one per cent of the population – as many as 80 million people worldwide – but for nearly 40 per cent of patients, it is misdiagnosed as major depressive disorder.

"People with bipolar disorder will experience periods of low mood and periods of very high mood or mania," said study first author Jakub Tomasik, from Cambridge's Department of Chemical Engineering and Biotechnology.

"But patients will often only see a doctor when they are experiencing low mood, which is why bipolar disorder frequently gets misdiagnosed as major depressive disorder," Tomasik said.

The most effective way to get an accurate diagnosis of bipolar disorder is a full psychiatric assessment. However, patients often face long waits to get these assessments, and they take time to carry out.

"Psychiatric assessments are highly effective, but the ability to diagnose bipolar disorder with a simple blood test could ensure that patients get the right treatment the first time and alleviate some of the pressures on medical professionals," said Tomasik.

The researchers used samples and data from the Delta study, conducted in the UK between 2018 and 2020, to identify bipolar disorder in patients who had received a diagnosis of major depressive disorder within the previous five years and had current depressive symptoms.

More than 3,000 participants were recruited, and they each completed an online mental health assessment of more than 600 questions. The assessment covered a range of topics that may be relevant to mental health disorders, including past or current depressive episodes, generalised anxiety, symptoms of mania, family history or substance abuse.

Of the participants who completed the online assessment, around 1,000 were selected to send in a dried blood sample from a simple finger prick, which the researchers analysed for more than 600 different metabolites using mass spectrometry.

After completing the Composite International Diagnostic Interview, a fully structured and validated diagnostic tool to establish mood disorder diagnoses, 241 participants were included in the study.

Analysis of the data showed a significant biomarker signal for bipolar disorder, even after accounting for confounding factors such as medication, the researchers said.

The biomarkers were correlated primarily with lifetime manic symptoms and were validated in a separate group of patients who received a new clinical diagnosis of major depressive disorder or bipolar disorder during the study's one-year follow-up period.

The researchers found that the combination of patient-reported information and the biomarker test significantly improved diagnostic outcomes for people with bipolar disorder, especially in those where the diagnosis was not obvious.

"The online assessment was more effective overall, but the biomarker test performs well and is much faster. A combination of both approaches would be ideal, as they are complementary," said professor Sabine Bahn, who led the research.

"We found that some patients preferred the biomarker test, because it was an objective result that they could see," Tomasik added.

(PTI)

More For You

Barbie with type 1 diabetes

This is also part of Mattel’s mission to extend the boundaries of imaginative play

Mattel

Mattel introduces first Barbie doll with type 1 diabetes to promote inclusion

Highlights

  • Mattel launches new Barbie with type 1 diabetes
  • The doll features a glucose monitor, insulin pump and CGM app
  • Created in collaboration with type 1 diabetes charity Breakthrough T1D
  • Part of Mattel’s broader push for inclusivity and representation in toys

Barbie with type 1 diabetes joins inclusive fashionistas range

Mattel has launched its first diabetes Barbie doll, designed to represent children with type 1 diabetes and promote greater inclusivity in children’s toys.

The new addition to the Barbie Fashionistas line comes with realistic medical features including a continuous glucose monitor (CGM) on her arm, secured with heart-shaped medical tape, and an insulin pump to help manage her blood sugar levels. She also carries a smartphone with a CGM app to monitor glucose throughout the day, and a bag large enough to store snacks and other essentials.

Keep ReadingShow less
Schiaparelli exhibition UK

Italian-born French fashion designer Elsa Schiaparelli

Getty Images

V&A announces UK’s first Schiaparelli exhibition as Natasha Poonawalla’s Met Gala looks make a comeback

“In difficult times fashion is always outrageous.” – Elsa Schiaparelli.

The Victoria & Albert Museum has announced its first ever UK exhibition dedicated to Elsa Schiaparelli, the visionary designer who blurred the boundaries between fashion, art and performance. Titled Schiaparelli: Fashion Becomes Art, it runs from 21 March to 1 November 2026 in the Sainsbury Gallery and will draw on the V&A’s status as home to Britain’s National Collection of Dress and its foremost collection of Schiaparelli garments.

Keep ReadingShow less
Martin Lewis warns shoppers

Lewis clarifies legal rights for online and in-store purchases

iStock

Martin Lewis warns shoppers about misleading return policies at 30 UK retailers

Highlights

  • Martin Lewis flags incorrect return rights information on 30 retail websites
  • Retailers include New Look, The Range, and Selfridges
  • Lewis clarifies legal rights for online and in-store purchases
  • Trading Standards to be alerted following MoneySavingExpert.com investigation

Martin Lewis highlights return rights confusion

Money-saving expert Martin Lewis has issued a warning to UK consumers after uncovering misleading returns information on the websites of 30 major retailers, including New Look, The Range, and Selfridges.

Speaking on ITV1's Good Morning Britain, Lewis explained that several retailers are presenting incorrect information about return rights for online shoppers — in some cases, underplaying the legal protections customers are entitled to.

Keep ReadingShow less
Gemma Collins Instagram ban

Collins accepted the findings of the ASA’s investigation

Getty Images

Gemma Collins’ Instagram post banned over weight-loss drug promotion

Highlights

  • Instagram post by Gemma Collins promoting Yazen weight-loss service banned
  • ASA rules it breached regulations on promoting prescription-only medication
  • Eight other weight-loss ads also banned in regulatory crackdown

ASA bans Collins' Instagram advert

An Instagram post by TV personality Gemma Collins promoting a weight-loss drug and digital service has been banned by the UK’s advertising watchdog for breaching regulations around prescription-only medicines.

Collins had shared a promotional video on 6 January 2025, stating: “I’m starting this year two sizes down, thanks to Yazen’s weight loss app and medication.” The Advertising Standards Authority (ASA) ruled that the post unlawfully promoted prescription-only medication to the public.

Keep ReadingShow less
5 secret beaches

Barafundle Bay, Pembrokeshire, Wales

iStock

5 secret beaches in the UK that feel like the tropics

Key points

  • Discover hidden UK beaches with turquoise waters and golden sands
  • Ideal for summer staycations without the cost of long-haul travel
  • Includes lesser-known spots in Wales, Scotland, Cornwall, and more
  • Perfect for quiet escapes, coastal walks, and Instagram-worthy views

Escape to paradise – no passport required

Think you need to fly halfway across the world for clear blue water and white sand? Think again. The UK is home to a surprising number of secluded beaches that look straight out of the Caribbean – without the crowds or jet lag. From hidden coves in Cornwall to windswept bays in the Scottish Highlands, here are some of the most tropical-looking beaches on British soil.

1. Barafundle Bay, Pembrokeshire, Wales

Often dubbed the UK’s answer to the Caribbean, this National Trust-owned gem boasts golden sand, crystal-clear waters, and dramatic cliffs. Accessed by a half-mile walk from Stackpole Quay, it remains blissfully untouched by development.

Keep ReadingShow less